Indian Journal of Endocrinology and Metabolism (Nov 2024)

Association Between Type 2 Diabetes and Hypogonadism in India: An Observational Study

  • Ambika G. Unnikrishnan,
  • Banshi D. Saboo,
  • Anirban Majumdar,
  • Ravi K. Saraogi,
  • Shanmuga Sundar,
  • Shriraam Mahadevan,
  • Anantharaman Ramakrishnan,
  • Indraneel Basu,
  • Deep Dutta,
  • Arpan D. Bhattacharya,
  • Prakadeesh Bharathi,
  • Kalpesh Gawand

DOI
https://doi.org/10.4103/ijem.ijem_262_23
Journal volume & issue
Vol. 28, no. 5
pp. 473 – 479

Abstract

Read online

Introduction: Hypogonadism is a common comorbidity associated with several metabolic disorders including type 2 diabetes (T2D) that can remain undetected without proper screening. Here, we evaluated the prevalence of hypogonadism in Indian male patients with T2D with or without obesity. Methods: In this prospective, observational study, male patients with T2D and hypogonadism were evaluated symptomatically using the androgen deficiency in ageing male (ADAM) questionnaire at baseline and confirmed on the basis of total testosterone (TT) levels (30 kg/m2 (obese) was 11.1%. At screening, 81.4% (487 of 598) patients had positive ADAM questionnaire results. Conclusions: Prevalence of hypogonadism in Indian patients with T2D was found to be 8.6% upon repeat evaluation of testosterone. Symptomatic (ADAM questionnaire) as well as biochemical (total testosterone levels with repeat evaluation) confirmation is vital in the definite diagnosis of male hypogonadism.

Keywords